ICD-10 Coding for Atypical Lobular Hyperplasia(D05.92, D05.92U, N60.89)
Learn about the ICD-10 coding for atypical lobular hyperplasia, including documentation requirements and common coding pitfalls.
Complete code families applicable to Atypical Lobular Hyperplasia
Key Information
Essential facts and insights aboutAtypical Lobular Hyperplasia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Atypical Lobular Hyperplasia.
Using 'lobular neoplasia' without specifying ALH or LCIS.
Impact
Clinical: May lead to inappropriate treatment plans., Regulatory: Could result in coding audits and penalties., Financial: Incorrect coding affects reimbursement accuracy.
Mitigation
Ensure clear documentation of the specific condition., Educate providers on the importance of precise terminology.
Coding ALH as lobular carcinoma in situ (D05.92)
Impact
Reimbursement: Incorrect coding may lead to inappropriate reimbursement rates., Compliance: May result in compliance issues due to misrepresentation of the patient's condition., Data Quality: Affects the accuracy of patient records and clinical data.
Mitigation
Ensure biopsy confirms ALH without malignancy before coding.
Misclassification of breast conditions
Impact
Risk of coding benign conditions as malignant.
Mitigation
Implement regular training for coders on differentiating benign and malignant breast conditions.